SELLAS Life Sciences Group, Inc. (SLS) NASDAQ

1.53

+0.035(+2.35%)

Updated at February 05 03:01PM

Currency In USD

Valuation

Market Cap29.44M
Enterprise Value27.82M
P/E Ratio-3.22
PEG Ratio-0.13
Price/Sales Ratio0
Price/Book Ratio6.55
Enterprise/Revenue0
Enterprise/EBITDA-6.65

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.22
Return On Equity-6.29

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA529,000
Net Income-37.34M
Diluted EPS-1.34

Balance Sheet

Total Cash21.03M
Total Cash/Share0.31
Total Debt576,000
Total Debt/Equity0.04
Current Ratio2.26
Book Value Per Share0.23

Price History

52-Week Change151.94
52-Week High1.84
52-Week Low0.65
Moving Average 50 Days1.08
Moving Average 200 Days1.22

Statistics

Average Volume2.68M
Shares Outstanding78.58M
% Held by Institutions7.89

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateNovember 08, 2019